Mapping from Disease-Specific Measures to Utility: An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's Disease and Measures of Utility-Reference-Cited by-同舟云学术

Mapping from Disease-Specific Measures to Utility: An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's Disease and Measures of Utility

Published:2007-05 Issue:3 Volume:10 Page:214-220
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Buxton Martin J.,Lacey Loretto A.,Feagan Brian G.,Niecko Timothy,Miller David W.,Townsend Raymond J.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference18 articles.

1. EuroQol—a new facility for the measurement of health-related quality of life;The EuroQol Group;Health Policy,1990

2. The estimation of a preference-based measure of health from the SF-36;Brazier;J Health Econ,2002

3. Multiattribute and single attribute utility functions for the health utilities index mark 3 system;Feeny;Med Care,2002

4. Mapping the SF-12 to the HUI3 and VAS in a managed care population;Sengupta;Med Care,2004

5. The relationship between health state utilities and the SF-12 in a general population;Lundberg;Med Decis Making,1999

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping IWQOL-Lite onto EQ-5D-5L and SF-6Dv2 among overweight and obese population in China;Quality of Life Research;2024-01-03

2. Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic Review;Journal of Crohn's and Colitis;2023-12-21

3. Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease;The European Journal of Health Economics;2023-06-27

4. The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission;The Lancet Gastroenterology & Hepatology;2023-05

5. Disutility Study for Adult Patients with Moderate to Severe Crohn’s Disease;Journal of Health Economics and Outcomes Research;2023